Item Type | Name |
Concept
|
Oligodeoxyribonucleotides, Antisense
|
Concept
|
Oligodeoxyribonucleotides
|
Academic Article
|
CpG oligodeoxynucleotides stimulate protective innate immunity against pulmonary Klebsiella infection.
|
Academic Article
|
C-Class CpG ODN: sequence requirements and characterization of immunostimulatory activities on mRNA level.
|
Academic Article
|
From A to Z on CpG.
|
Academic Article
|
CPG 7909, an immunostimulatory TLR9 agonist oligodeoxynucleotide, as adjuvant to Engerix-B HBV vaccine in healthy adults: a double-blind phase I/II study.
|
Academic Article
|
Induction of systemic TH1-like innate immunity in normal volunteers following subcutaneous but not intravenous administration of CPG 7909, a synthetic B-class CpG oligodeoxynucleotide TLR9 agonist.
|
Academic Article
|
Impact of class A, B and C CpG-oligodeoxynucleotides on in vitro activation of innate immune cells in human immunodeficiency virus-1 infected individuals.
|
Academic Article
|
Role of mitogen-activated protein kinases in CpG DNA-mediated IL-10 and IL-12 production: central role of extracellular signal-regulated kinase in the negative feedback loop of the CpG DNA-mediated Th1 response.
|
Academic Article
|
Inhibitory oligonucleotides specifically block effects of stimulatory CpG oligonucleotides in B cells.
|
Academic Article
|
Immunostimulatory oligodeoxynucleotides containing CpG motifs enhance the efficacy of monoclonal antibody therapy of lymphoma.
|
Academic Article
|
Rapid and strong human CD8+ T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909.
|
Academic Article
|
Biodistribution and metabolism of immunostimulatory oligodeoxynucleotide CPG 7909 in mouse and rat tissues following subcutaneous administration.
|
Academic Article
|
Antitumor mechanisms of oligodeoxynucleotides with CpG and polyG motifs in murine prostate cancer cells: decrease of NF-kappaB and AP-1 binding activities and induction of apoptosis.
|
Academic Article
|
Highly immunostimulatory CpG-free oligodeoxynucleotides for activation of human leukocytes.
|
Academic Article
|
CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity.
|
Academic Article
|
Unmethylated CpG-containing oligodeoxynucleotides inhibit apoptosis in WEHI 231 B lymphocytes induced by several agents: evidence for blockade of apoptosis at a distal signalling step.
|
Academic Article
|
Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization.
|
Academic Article
|
Deoxycytidyl-deoxyguanosine oligonucleotide classes A, B, and C induce distinct cytokine gene expression patterns in rhesus monkey peripheral blood mononuclear cells and distinct alpha interferon responses in TLR9-expressing rhesus monkey plasmacytoid dendritic cells.
|
Academic Article
|
Modulation of airway inflammation by CpG oligodeoxynucleotides in a murine model of asthma.
|
Academic Article
|
CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen.
|
Academic Article
|
CpG oligodeoxyribonucleotides rescue mature spleen B cells from spontaneous apoptosis and promote cell cycle entry.
|
Academic Article
|
CpG DNA rescue of murine B lymphoma cells from anti-IgM-induced growth arrest and programmed cell death is associated with increased expression of c-myc and bcl-xL.
|
Academic Article
|
CpG oligodeoxynucleotides augment the murine immune response to the Yersinia pestis F1-V vaccine in bubonic and pneumonic models of plague.
|
Academic Article
|
CpG oligodeoxynucleotides stimulate IFN-gamma-inducible protein-10 production in human B cells.
|
Academic Article
|
The ability of CpG oligonucleotides to protect mice against Francisella tularensis live vaccine strain but not fully virulent F. tularensis subspecies holarctica is reflected in cell-based assays.
|
Academic Article
|
Paradoxical enhancement of CD8 T cell-dependent anti-tumor protection despite reduced CD8 T cell responses with addition of a TLR9 agonist to a tumor vaccine.
|
Academic Article
|
Antiinfective applications of toll-like receptor 9 agonists.
|
Academic Article
|
Lymphoma immunotherapy with CpG oligodeoxynucleotides requires TLR9 either in the host or in the tumor itself.
|
Academic Article
|
CpG DNA rescue from anti-IgM-induced WEHI-231 B lymphoma apoptosis via modulation of I kappa B alpha and I kappa B beta and sustained activation of nuclear factor-kappa B/c-Rel.
|
Academic Article
|
Safety, pharmacokinetics and immune effects in normal volunteers of CPG 10101 (ACTILON), an investigational synthetic toll-like receptor 9 agonist.
|
Academic Article
|
Cyclosporin A enhances IL-12 production by CpG motifs in bacterial DNA and synthetic oligodeoxynucleotides.
|
Academic Article
|
CpG ODN enhances uptake of bacteria by mouse macrophages.
|
Academic Article
|
CpG DNA can induce strong Th1 humoral and cell-mediated immune responses against hepatitis B surface antigen in young mice.
|
Academic Article
|
CpG-A-induced monocyte IFN-gamma-inducible protein-10 production is regulated by plasmacytoid dendritic cell-derived IFN-alpha.
|
Academic Article
|
Phase I trial of toll-like receptor 9 agonist PF-3512676 with and following rituximab in patients with recurrent indolent and aggressive non Hodgkin's lymphoma.
|
Academic Article
|
CpG oligonucleotides protect against Venezuelan equine encephalitis virus infection in a route-dependent manner.
|
Academic Article
|
CpG oligodeoxynucleotide enhances immunity against blood-stage malaria infection in mice parenterally immunized with a yeast-expressed 19 kDa carboxyl-terminal fragment of Plasmodium yoelii merozoite surface protein-1 (MSP1(19)) formulated in oil-based Montanides.
|
Academic Article
|
CpG still rocks! Update on an accidental drug.
|
Academic Article
|
Activation of innate immunity in healthy Macaca mulatta macaques by a single subcutaneous dose of GMP CpG 7909: safety data and interferon-inducible protein-10 kinetics for humans and macaques.
|
Academic Article
|
CpG motifs in bacterial DNA and their immune effects.
|
Academic Article
|
Stimulation via Toll-like receptor 9 reduces Cryptococcus neoformans-induced pulmonary inflammation in an IL-12-dependent manner.
|
Academic Article
|
Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances tumor response to fractionated radiotherapy.
|
Academic Article
|
Identification of an oligodeoxynucleotide sequence motif that specifically inhibits phosphorylation by protein tyrosine kinases.
|
Academic Article
|
CpG-DNA protects against a lethal orthopoxvirus infection in a murine model.
|
Academic Article
|
Combining vaccination and postexposure CpG therapy provides optimal protection against lethal sepsis in a biodefense model of human melioidosis.
|
Academic Article
|
PD-1 and Tim-3 regulate the expansion of tumor antigen-specific CD8? T cells induced by melanoma vaccines.
|
Academic Article
|
Clinical evaluation of safety and immunogenicity of PADRE-cytomegalovirus (CMV) and tetanus-CMV fusion peptide vaccines with or without PF03512676 adjuvant.
|
Academic Article
|
CpG oligodeoxynucleotides down-regulate macrophage class II MHC antigen processing.
|
Academic Article
|
Oral pretreatment of mice with CpG DNA reduces susceptibility to oral or intraperitoneal challenge with virulent Listeria monocytogenes.
|
Academic Article
|
CpG oligodeoxynucleotides potentiate the antitumor effects of chemotherapy or tumor resection in an orthotopic murine model of rhabdomyosarcoma.
|
Academic Article
|
Inhibitory oligonucleotides block the induction of AP-1 transcription factor by stimulatory CpG oligonucleotides in B cells.
|
Academic Article
|
CpG oligodeoxynucleotides do not require TH1 cytokines to prevent eosinophilic airway inflammation in a murine model of asthma.
|
Academic Article
|
CpG DNA rescues B cells from apoptosis by activating NFkappaB and preventing mitochondrial membrane potential disruption via a chloroquine-sensitive pathway.
|
Academic Article
|
Interruption of a transforming growth factor alpha autocrine loop in Caco-2 cells by antisense oligodeoxynucleotides.
|
Academic Article
|
The role of CpG motifs in innate immunity.
|
Academic Article
|
Attenuated cytokine responses in porcine lymph node cells stimulated with CpG DNA are associated with low frequency of IFNalpha-producing cells and TLR9 mRNA expression.
|
Academic Article
|
CpG DNA: trigger of sepsis, mediator of protection, or both?
|
Academic Article
|
Mechanisms and applications of immune stimulatory CpG oligodeoxynucleotides.
|
Academic Article
|
Immunostimulatory CpG oligodeoxynucleotides enhance the immune response to vaccine strategies involving granulocyte-macrophage colony-stimulating factor.
|
Academic Article
|
CpG oligonucleotides enhance the tumor antigen-specific immune response of an anti-idiotype antibody-based vaccine strategy in CEA transgenic mice.
|
Academic Article
|
CpG oligodeoxynucleotides can circumvent the Th2 polarization of neonatal responses to vaccines but may fail to fully redirect Th2 responses established by neonatal priming.
|
Academic Article
|
CPG 7909 adjuvant improves hepatitis B virus vaccine seroprotection in antiretroviral-treated HIV-infected adults.
|
Academic Article
|
Bacterial DNA and CpG-containing oligodeoxynucleotides activate cutaneous dendritic cells and induce IL-12 production: implications for the augmentation of Th1 responses.
|
Academic Article
|
Immunostimulatory oligodeoxynucleotides promote protective immunity and provide systemic therapy for leishmaniasis via IL-12- and IFN-gamma-dependent mechanisms.
|
Academic Article
|
CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cells.
|
Academic Article
|
The Toll-like receptor 7 (TLR7) agonist, imiquimod, and the TLR9 agonist, CpG ODN, induce antiviral cytokines and chemokines but do not prevent vaginal transmission of simian immunodeficiency virus when applied intravaginally to rhesus macaques.
|
Academic Article
|
Synthetic oligodeoxynucleotides containing CpG motifs enhance immunogenicity of a peptide malaria vaccine in Aotus monkeys.
|
Academic Article
|
Antibody repertoire development in fetal and neonatal piglets. IX. Three pathogen-associated molecular patterns act synergistically to allow germfree piglets to respond to type 2 thymus-independent and thymus-dependent antigens.
|
Academic Article
|
A novel class of immune-stimulatory CpG oligodeoxynucleotides unifies high potency in type I interferon induction with preferred structural properties.
|
Academic Article
|
Mechanism and function of a newly identified CpG DNA motif in human primary B cells.
|
Academic Article
|
Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo.
|
Academic Article
|
A CpG oligonucleotide can protect mice from a low aerosol challenge dose of Burkholderia mallei.
|
Academic Article
|
Inhibition of T4 polynucleotide kinase activity by phosphorothioate and chimeric oligodeoxynucleotides.
|
Academic Article
|
CpG oligodeoxynucleotide and Montanide ISA 51 adjuvant combination enhanced the protective efficacy of a subunit malaria vaccine.
|
Academic Article
|
Antitumor applications of stimulating toll-like receptor 9 with CpG oligodeoxynucleotides.
|
Academic Article
|
APC stimulated by CpG oligodeoxynucleotide enhance activation of MHC class I-restricted T cells.
|
Academic Article
|
Enhanced dendritic cell maturation by TNF-alpha or cytidine-phosphate-guanosine DNA drives T cell activation in vitro and therapeutic anti-tumor immune responses in vivo.
|
Academic Article
|
CpG DNA is an effective oral adjuvant to protein antigens in mice.
|
Academic Article
|
CpG DNA induces maturation of dendritic cells with distinct effects on nascent and recycling MHC-II antigen-processing mechanisms.
|
Academic Article
|
P-chirality-dependent immune activation by phosphorothioate CpG oligodeoxynucleotides.
|
Academic Article
|
Therapeutic potential of Toll-like receptor 9 activation.
|
Academic Article
|
Adjuvant effects of CpG oligodeoxynucleotides on responses against T-independent type 2 antigens.
|
Academic Article
|
Activation of plasmacytoid dendritic cells with TLR9 agonists initiates invariant NKT cell-mediated cross-talk with myeloid dendritic cells.
|
Academic Article
|
Randomized phase II trial of a toll-like receptor 9 agonist oligodeoxynucleotide, PF-3512676, in combination with first-line taxane plus platinum chemotherapy for advanced-stage non-small-cell lung cancer.
|
Academic Article
|
Immunopharmacology of CpG oligodeoxynucleotides and ribavirin.
|
Academic Article
|
Paclitaxel reduces regulatory T cell numbers and inhibitory function and enhances the anti-tumor effects of the TLR9 agonist PF-3512676 in the mouse.
|
Academic Article
|
Induction of autoantibody production but not autoimmune disease in HEL transgenic mice vaccinated with HEL in combination with CpG or control oligodeoxynucleotides.
|
Academic Article
|
Impact of modifications of heterocyclic bases in CpG dinucleotides on their immune-modulatory activity.
|
Academic Article
|
CpG DNA induces cyclooxygenase-2 expression and prostaglandin production.
|
Academic Article
|
Modification of antisense phosphodiester oligodeoxynucleotides by a 5' cholesteryl moiety increases cellular association and improves efficacy.
|
Academic Article
|
Synthetic unmethylated cytosine-phosphate-guanosine oligodeoxynucleotides are potent stimulators of antileukemia responses in naive and bone marrow transplant recipients.
|
Academic Article
|
CpG DNA overcomes hyporesponsiveness to hepatitis B vaccine in orangutans.
|
Academic Article
|
Positive T cell co-stimulation by TLR7/8 ligands is dependent on the cellular environment.
|
Academic Article
|
Subcutaneous, but not intratracheal administration of the TLR9 agonist, CpG DNA transiently reduces parainfluenza-3 virus shedding in newborn lambs.
|
Academic Article
|
CpG motifs in bacterial DNA trigger direct B-cell activation.
|
Academic Article
|
Signal transduction induced by immunostimulatory CpG DNA.
|
Academic Article
|
CpG oligonucleotides as immune adjuvants.
|
Academic Article
|
Stimulation of innate immune responses by CpG oligodeoxynucleotide in newborn lambs can reduce bovine herpesvirus-1 shedding.
|
Academic Article
|
Immunostimulatory effects of three classes of CpG oligodeoxynucleotides on PBMC from HCV chronic carriers.
|
Academic Article
|
Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities.
|
Academic Article
|
A possible cause of joint destruction in septic arthritis.
|
Academic Article
|
A combination of Flt3 ligand cDNA and CpG ODN as nasal adjuvant elicits NALT dendritic cells for prolonged mucosal immunity.
|
Academic Article
|
Whole blood cultures to assess the immunostimulatory activities of CpG oligodeoxynucleotides.
|
Academic Article
|
Modulating responsiveness of human TLR7 and 8 to small molecule ligands with T-rich phosphorothiate oligodeoxynucleotides.
|
Academic Article
|
Interleukin-12- and gamma interferon-dependent protection against malaria conferred by CpG oligodeoxynucleotide in mice.
|
Academic Article
|
CpG DNA increases primary malignant B cell expression of costimulatory molecules and target antigens.
|
Academic Article
|
Modulation of CpG oligodeoxynucleotide-mediated immune stimulation by locked nucleic acid (LNA).
|
Academic Article
|
Enhancing vaccines with immune stimulatory CpG DNA.
|
Academic Article
|
New generation vaccine induces effective melanoma-specific CD8+ T cells in the circulation but not in the tumor site.
|
Academic Article
|
Surgical excision combined with autologous whole tumor cell vaccination is an effective therapy for murine neuroblastoma.
|
Academic Article
|
Decreased cytotoxic T cell activity generated by co-administration of PSA vaccine and CpG ODN is associated with increased tumor protection in a mouse model of prostate cancer.
|
Academic Article
|
Immunization with analog peptide in combination with CpG and montanide expands tumor antigen-specific CD8+ T cells in melanoma patients.
|
Academic Article
|
From bugs to drugs: therapeutic immunomodulation with oligodeoxynucleotides containing CpG sequences from bacterial DNA.
|
Academic Article
|
Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells.
|
Academic Article
|
Oligodeoxynucleotide CpG 7909 delivered as intravenous infusion demonstrates immunologic modulation in patients with previously treated non-Hodgkin lymphoma.
|
Academic Article
|
Dendritic cells pulsed or fused with AML cellular antigen provide comparable in vivo antitumor protective responses.
|
Academic Article
|
Uptake of oligodeoxyribonucleotides by lymphoid cells is heterogeneous and inducible.
|
Academic Article
|
Immunostimulatory CpG oligodeoxynucleotide confers protection in a murine model of infection with Burkholderia pseudomallei.
|
Academic Article
|
Type I interferon is the primary regulator of inducible Ly-6C expression on T cells.
|
Academic Article
|
CpG stimulation of primary mouse B cells is blocked by inhibitory oligodeoxyribonucleotides at a site proximal to NF-kappaB activation.
|
Academic Article
|
CpG oligodeoxynucleotide enhances tumor response to radiation.
|
Academic Article
|
Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12.
|
Academic Article
|
CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma.
|
Academic Article
|
Bacterial DNA induces NK cells to produce IFN-gamma in vivo and increases the toxicity of lipopolysaccharides.
|
Academic Article
|
Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells.
|
Academic Article
|
CpG motif identification for veterinary and laboratory species demonstrates that sequence recognition is highly conserved.
|
Academic Article
|
Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists.
|
Academic Article
|
CpG DNA induces sustained IL-12 expression in vivo and resistance to Listeria monocytogenes challenge.
|
Academic Article
|
Reduction of antigen expression from DNA vaccines by coadministered oligodeoxynucleotides.
|
Academic Article
|
Lactoferrin binds CpG-containing oligonucleotides and inhibits their immunostimulatory effects on human B cells.
|
Academic Article
|
Toll-like receptor 9 activation with CpG oligodeoxynucleotides for asthma therapy.
|
Academic Article
|
IFN-gamma promotes IL-6 and IgM secretion in response to CpG motifs in bacterial DNA and oligodeoxynucleotides.
|
Academic Article
|
Safety and immunogenicity of CPG 7909 injection as an adjuvant to Fluarix influenza vaccine.
|
Academic Article
|
Enhancement of infectious disease vaccines through TLR9-dependent recognition of CpG DNA.
|
Academic Article
|
Innate immune responses induced by classes of CpG oligodeoxynucleotides in ovine lymph node and blood mononuclear cells.
|
Academic Article
|
Divergent therapeutic and immunologic effects of oligodeoxynucleotides with distinct CpG motifs.
|
Academic Article
|
Distinct CpG oligonucleotide sequences activate human gamma delta T cells via interferon-alpha/-beta.
|
Academic Article
|
Comparison of CpG s-ODNs, chromatin immune complexes, and dsDNA fragment immune complexes in the TLR9-dependent activation of rheumatoid factor B cells.
|
Academic Article
|
Oligodeoxynucleotides lacking CpG dinucleotides mediate Toll-like receptor 9 dependent T helper type 2 biased immune stimulation.
|
Academic Article
|
High mobility group B1 protein suppresses the human plasmacytoid dendritic cell response to TLR9 agonists.
|
Academic Article
|
Systemic innate immune responses following intrapulmonary delivery of CpG oligodeoxynucleotides in sheep.
|
Academic Article
|
Phosphorothioate oligodeoxynucleotides: antisense or anti-protein?
|
Academic Article
|
Enhanced antibody responses elicited by a CpG adjuvant do not improve the protective effect of an aldrithiol-2-inactivated simian immunodeficiency virus therapeutic AIDS vaccine.
|
Academic Article
|
Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA.
|
Academic Article
|
CpG are efficient adjuvants for specific CTL induction against tumor antigen-derived peptide.
|
Academic Article
|
Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: a role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA.
|
Academic Article
|
Monocytes are required for optimum in vitro stimulation of bovine peripheral blood mononuclear cells by non-methylated CpG motifs.
|
Academic Article
|
Protection of Mice from Lethal Vaccinia Virus Infection by Vaccinia Virus Protein Subunits with a CpG Adjuvant.
|
Academic Article
|
Antibody Opsonization of a TLR9 Agonist-Containing Virus-like Particle Enhances In Situ Immunization.
|